Doxorubicin (Doxo) is a widely used chemotherapeutic drug for cancer, though it can have toxic effects on the heart. A recent animal study published in The FASEB Journal investigated whether the cardioregulatory protein chromogranin ...
Apr 11, 2019
0
1
Scientists at the University of Huddersfield aim to minimise, or eliminate completely, the hair loss that is one of the most distressing side-effects of cancer treatment. They aim to achieve this by combining scalp cooling ...
Apr 11, 2019
0
3
Hairlessness in dogs can be the result of deliberate breeding or, in certain breeds, a defect. A recent study completed at the University of Helsinki describes a gene variant in the SGK3 gene, which causes hairlessness in ...
Apr 02, 2019
0
1
Have you ever experienced a constant ringing in your ears that you can't pinpoint the cause? It might be tinnitus ('tin-ni-tus) - the sensation of hearing a sound when no external sound is present. In most cases, tinnitus ...
Mar 13, 2019
0
2
Researchers at the University of Virginia School of Medicine have discovered a new potential contributor to age-related hearing loss, a finding that could eventually help doctors identify people at risk.
Mar 12, 2019
0
18
A new "smart drug" has shown promise for women with metastatic triple-negative breast cancer, based on data from a clinical trial at NewYork-Presbyterian/Columbia's Herbert Irving Comprehensive Cancer Center and other centers. ...
Feb 20, 2019
0
3578
Hypotrichosis simplex leads to progressive hair loss as early as childhood. A team of researchers led by human geneticists at the University Hospital of Bonn has now found a gene that is responsible for this rare form of ...
Nov 07, 2018
0
3
In experiments using mice, a team of UC San Francisco researchers has discovered a gene that plays an essential role in noise-induced deafness. Remarkably, by administering an experimental chemical—identified in a separate ...
Oct 19, 2018
0
3
Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric (OG cancer): a pooled analysis of 4 randomised trials.
Oct 19, 2018
0
1
Massachusetts General Hospital (MGH) physicians are reporting an unexpected side-effect from treatment with dupilumab, which is FDA approved for the treatment of moderate to severe eczema, also called atopic dermatitis. In ...
Oct 10, 2018
0
223
